Regulation of MYCN expression in human neuroblastoma cells

BMC Cancer

Volumn 9, Issue , 2009, Pages

  Jacobs, Joannes F M ^a,b   van Bokhoven, Hans ^a   van Leeuwen, Frank N ^b   Hulsbergen van de Kaa, Christina A ^b   de Vries, I J M ^a,b   Adema, Gosse J ^a   Hoogerbrugge, Peter M ^b   De Brouwer, Arjan P M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; MYC PROTEIN; MESSENGER RNA; MYCN PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CHILD; CONTROLLED STUDY; FEMALE; GENE DOSAGE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MALE; MYCN OPPOSITE STRAND GENE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; ONCOGENE; ONCOGENE C MYB; PRESCHOOL CHILD; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SHORTENED MYCN GENE; BIOSYNTHESIS; GENETICS; METABOLISM; NEWBORN; PATHOLOGY;

CHILD; CHILD, PRESCHOOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFANT; INFANT, NEWBORN; NEOPLASM STAGING; NEUROBLASTOMA; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 68249152597     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-239     Document Type: Article

References (31)

1. Bordow SB, Norris MD, Haber PS, Marshall GM, Haber M. Prognostic significance of MYCN oncogene expression in childhood neuroblastoma. J Clin Oncol 1998, 16:3286-3294.
2. Matthay KK. MYCN expression in neuroblastoma: A mixed message?. J Clin Oncol 2000, 18:3591-3594.
3. Tang XX, Zhao H, Kung B, Kim DY, Hicks SL, Cohn SL, Cheung NK, Seeger RC, Evans AE, Ikegaki N. The MYCN enigma: significance of MYCN expression in neuroblastoma. Cancer Res 2006, 66:2826-2833. 10.1158/0008-5472.CAN-05-0854, 16510605.
4. Scott D, Elsden J, Pearson A, Lunec J. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype?. Cancer Lett 2003, 197:81-86. 10.1016/S0304-3835(03)00086-7, 12880964.
5. Schwab M. MYCN in neuronal tumours. Cancer Lett 2004, 204:179-187. 10.1016/S0304-3835(03)00454-3, 15013217.
6. De Preter K, Speleman F, Combaret V, Lunec J, Laureys G, Eussen BH, Francotte N, Board J, Pearson AD, De Paepe A, Van Roy N, Vandesompele J. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. Mod Pathol 2002, 15:159-166. 10.1038/modpathol.3880508, 11850545.
7. Lehner B, Williams G, Campbell RD, Sanderson CM. Antisense transcripts in the human genome. Trends Genet 2002, 18:63-65. 10.1016/S0168-9525(02)02598-2, 11818131.
8. Shendure J, Church GM. Computational discovery of sense-antisense transcription in the human and mouse genomes. Genome Biol 2002, 3:RESEARCH0044. 126869, 12225583, 10.1186/gb-2002-3-9-research0044.
9. Misra S, Crosby MA, Mungall CJ, Matthews BB, Campbell KS, Hradecky P, Huang Y, Kaminker JS, Millburn GH, Prochnik SE, Smith CD, Tupy JL, Whitfied EJ, Bayraktaroglu L, Berman BP, Bettencourt BR, Celniker SE, de Grey AD, Drysdale RA, Harris NL, Richter J, Russo S, Schroeder AJ, Shu SQ, Stapleton M, Yamada C, Ashburner M, Gelbart WM, Rubin GM, Lewis SE. Annotation of the Drosophila melanogaster euchromatic genome: a systematic review. Genome Biol 2002, 3:RESEARCH0083. 151185, 12537572, 10.1186/gb-2002-3-12-research0083.
10. Yelin R, Dahary D, Sorek R, Levanon EY, Goldstein O, Shoshan A, Diber A, Biton S, Tamir Y, Khosravi R, Nemzer S, Pinner E, Walach S, Bernstein J, Savitsky K, Rotman G. Widespread occurrence of antisense transcription in the human genome. Nat Biotechnol 2003, 21:379-386. 10.1038/nbt808, 12640466.
11. Lavorgna G, Dahary D, Lehner B, Sorek R, Sanderson CM, Casari G. In search of antisense. Trends Biochem Sci 2004, 29:88-94. 10.1016/j.tibs.2003.12.002, 15102435.
12. Makalowska I, Lin CF, Makalowski W. Overlapping genes in vertebrate genomes. Comput Biol Chem 2005, 29:1-12. 10.1016/j.compbiolchem.2004.12.006, 15680581.
13. Armstrong BC, Krystal GW. Isolation and characterization of complementary DNA for N-cym, a gene encoded by the DNA strand opposite to N-myc. Cell Growth Differ 1992, 3:385-390.
14. Thrash-Bingham CA, Tartof KD. aHIF a natural antisense transcript overexpressed in human renal cancer and during hypoxia. J Natl Cancer Inst 1999, 91:143-151. 10.1093/jnci/91.2.143, 9923855.
15. Baguma-Nibasheka M, Li AW, Osman MS, Geldenhuys L, Casson AG, Too CK, Murphy PR. Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells. Leuk Res 2005, 29:423-433. 10.1016/j.leukres.2004.09.006, 15725477.
16. Rossignol F, Vache C, Clottes E. Natural antisense transcripts of hypoxia-inducible factor 1alpha are detected in different normal and tumour human tissues. Gene 2002, 299:135-140. 10.1016/S0378-1119(02)01049-1, 12459261.
17. Cayre A, Rossignol F, Clottes E, Penault-Llorca F. aHIF but not HIF-1alpha transcript is a poor prognostic marker in human breast cancer. Breast Cancer Res 2003, 5:R223-230. 314412, 14580258, 10.1186/bcr652.
18. van Bokhoven H, Celli J, van Reeuwijk J, Rinne T, Glaudemans B, van Beusekom E, Rieu P, Newbury-Ecob RA, Chiang C, Brunner HG. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat Genet 2005, 37:465-467. 10.1038/ng1546, 15821734.
19. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
20. Marcelis CL, Hol FA, Graham GE, Rieu PN, Kellermayer R, Meijer RP, Lugtenberg D, Scheffer H, van Bokhoven H, Brunner HG, de Brouwer APM. Genotype-phenotype correlations in MYCN-related Feingold syndrome. Hum Mutat 2008, 29:1125-1132. 10.1002/humu.20750, 18470948.
21. de Brouwer AP, van Bokhoven H, Kremer H. Comparison of 12 reference genes for normalization of gene expression levels in Epstein-Barr virus-transformed lymphoblastoid cell lines and fibroblasts. Mol Diagn Ther 2006, 10:197-204.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
23. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45. 55695, 11328886, 10.1093/nar/29.9.e45.
24. Hoebeeck J, Speleman F, Vandesompele J. Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. Methods Molecular Biol 2007, 353:205-226.
25. Shimada H, Umehara S, Monobe Y, Hachitanda Y, Nakagawa A, Goto S, Gerbing RB, Stram DO, Lukens JN, Matthay KK. International neuroblastoma pathology classification for prognostic evaluation of patients with peripheral neuroblastic tumors: a report from the Children's Cancer Group. Cancer 2001, 92:2451-2461. 10.1002/1097-0142(20011101)92:9<2451::AID-CNCR1595>3.0.CO;2-S, 11745303.
26. Tanaka S, Tajiri T, Noguchi S, Shono K, Ihara K, Hara T, Suita S. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma. J Pediatr Surg 2004, 39:63-68. 10.1016/j.jpedsurg.2003.09.015, 14694373.
27. Corvi R, Savelyeva L, Schwab M. Duplication of N-MYC at its resident site 2p24 may be a mechanism of activation alternative to amplification in human neuroblastoma cells. Cancer Res 1995, 55:3471-3474.
28. Schwab M, Ellison J, Busch M, Rosenau W, Varmus HE, Bishop JM. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proc Natl Acad Sci USA 1984, 81:4940-4944. 391608, 6589638, 10.1073/pnas.81.15.4940.
29. Krystal GW, Armstrong BC, Battey JF. N-myc mRNA forms an RNA-RNA duplex with endogenous antisense transcripts. Mol Cell Biol 1990, 10(8):4180-4191. 360949, 1695323.
30. Stanton LW, Bishop JM. Alternative processing of RNA transcribed from NMYC. Mol Cell Biol 1987, 7:4266-4272. 368108, 3437890.
31. Nickerson HJ, Matthay KK, Seeger RC, Brodeur GM, Shimada H, Perez C, Atkinson JB, Selch M, Gerbing RB, Stram DO, Lukens J. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol 2000, 18:477-486.